Out of more than a hundred cannabinoids that have so far been identified in the cannabis sativa plant, the non-intoxicating cannabidivarin (CBDV)... read more →
It is hoped that the pure ingredient will open up new research prospects for pharma, wellness industry, and other market players.
... read more →
Sanobiotec aims to improve the technological processes for production of these compounds and leverage their therapeutic benefits for pharmaceuticals, wellness industry and treatment of progressive illnesses, such as cancer or Alzheimer’s.... read more →
To my great pleasure, I received the notification last Monday that the reviewers in a lengthy, two-stage assessment process recommended our study “Efficacy and Safety of Psilocybin in Treatment-Resistant... read more →
Even before COVID-19 set off a global tsunami of anxiety and depression, psychedelic drugs were already showing exciting promise for treating these and other intractable mental health conditions.... read more →